Cargando…

New perspectives in the management of small cell lung cancer

The treatment of small cell lung cancer (SCLC) is a challenge for all specialists involved. New treatments have been added to the therapeutic armamentarium in recent months, but efforts must continue to improve both survival and quality of life. Advances in surgery and radiotherapy have resulted in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pangua, Cristina, Rogado, Jacobo, Serrano-Montero, Gloria, Belda-Sanchís, José, Álvarez Rodríguez, Beatriz, Torrado, Laura, Rodríguez De Dios, Nuria, Mielgo-Rubio, Xabier, Trujillo, Juan Carlos, Couñago, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244973/ https://www.ncbi.nlm.nih.gov/pubmed/35949427 http://dx.doi.org/10.5306/wjco.v13.i6.429

Ejemplares similares

Characteristics and outcome of lung cancer patients and Covid-19 infection in a second-level hospital during the first 3 months of the pandemic()
por: Rogado, Jacobo, et al.
Publicado: (2020)

Características y evolución de los pacientes con cáncer de pulmón e infección Covid-19 en un hospital de segundo nivel durante los 3 primeros meses de pandemia
por: Rogado, Jacobo, et al.
Publicado: (2020)

New potential targeted strategies in small cell lung cancer
por: de Toro, María, et al.
Publicado: (2023)

Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022)

Prevalence of thrombosis in patients with cancer and SARS-CoV-2 infection
por: Obispo, Berta, et al.
Publicado: (2022)

COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic()
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)

Mortalidad por COVID-19 en pacientes con cáncer en un hospital de Madrid durante las primeras 3 semanas de epidemia
por: Lara Álvarez, Miguel Ángel, et al.
Publicado: (2020)

Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
por: Aguado, Carlos, et al.
Publicado: (2022)

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)

Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
por: Sereno, María, et al.
Publicado: (2021)

Covid-19 and lung cancer: A greater fatality rate?
por: Rogado, Jacobo, et al.
Publicado: (2020)

Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies
por: Martin, Margarita, et al.
Publicado: (2022)

Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
por: Olmedo, Maria Eugenia, et al.
Publicado: (2022)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Tsunami of immunotherapy reaches mesothelioma
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2022)

Coronavirus disease 2019 and lung cancer: where are we?
por: Ocanto, Abrahams, et al.
Publicado: (2023)

GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic
por: Couñago, Felipe, et al.
Publicado: (2020)

Neoadjuvant immunotherapy in non-small-cell lung cancer: Times are changing—and fast
por: Aguado, Carlos, et al.
Publicado: (2022)

1771P Do breast cancer patients with COVID-19 have a poor prognosis? Experience in a hospital in Madrid
por: Obispo, B., et al.
Publicado: (2020)

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid
por: Rogado, J., et al.
Publicado: (2020)

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

1685P Is cancer what determines COVID-19 oncological patient’s outcome or are other external factors involved? Experience in a hospital in Madrid, Spain
por: Rogado, J., et al.
Publicado: (2020)

Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors
por: Rogado, Jacobo, et al.
Publicado: (2021)

1573P First wave mortality data versus full pandemic period from the COVID-CANCER HUIL study
por: Serrano-Montero, G., et al.
Publicado: (2021)

1576P COVID-CANCER HUIL - Registry of oncological patients with diagnosis of COVID-19 at Hospital Universitario Infanta Leonor in Madrid (Spain): One year of pandemic
por: Rogado, J., et al.
Publicado: (2021)

GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer
por: Rodríguez De Dios, Núria, et al.
Publicado: (2022)

Immunotherapy in non-small cell lung cancer: Update and new insights
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
por: Fernández, Castalia, et al.
Publicado: (2022)

1766P COVID-19 and lung cancer: What do we know?
por: Serrano, G., et al.
Publicado: (2020)

High tumor burden in non-small-cell lung cancer: A review of the literature
por: Cabezón-Gutiérrez, Luis, et al.
Publicado: (2022)

Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer
por: Montemuiño Muñiz, Sara, et al.
Publicado: (2021)

Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19
por: Rogado, Jacobo, et al.
Publicado: (2021)

The Other Cost of the Pandemic
por: Obispo, Berta, et al.
Publicado: (2022)

The current role of surgery and SBRT in early stage of small cell lung cancer
por: Farré, Núria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sfoc4elafq8sqo2i19c08ufmnu